Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (51-60 of 426) with videos related to

Pageof 43
Sort By:
European Journal of Medicinal Chemistry|January 23, 2018
Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1KaiJun Jin, Hong Yin, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|October 7, 2008
Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of actionTine Van Neck, Christophe Pannecouque, Els Vanstreels, et al.
European Journal of Medicinal Chemistry|September 21, 2014
Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridizationZhaoqiang Liu, Wenmin Chen, Peng Zhan, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2014
Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19Rosalba Perrone, Elena Butovskaya, Dirk Daelemans, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
How a modification (8-aza-3-deaza-2'-deoxyguanosine) influences the quadruplex structure of Hotoda's 6-mer TGGGAG with 5'- and 3'-end modificationsSuzana Jaksa, Bogdan Kralj, Christophe Pannecouque, et al.
European Journal of Medicinal Chemistry|February 5, 2008
Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agentsRavindra K Rawal, Rajkamal Tripathi, S B Katti, et al.
European Journal of Medicinal Chemistry|August 12, 2008
Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitorsYue-Ping Wang, Fen-Er Chen, Erik De Clercq, et al.
Chemistry & Biodiversity|April 9, 2009
Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strainYuan-Zhen Xiong, Fen-Er Chen, Jan Balzarini, et al.
European Journal of Medicinal Chemistry|September 18, 2007
Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activityYuan-Zhen Xiong, Fen-Er Chen, Jan Balzarini, et al.
European Journal of Medicinal Chemistry|July 25, 2009
Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsPeng Zhan, Xinyong Liu, Zengjun Fang, et al.
Pageof 43

Showing results (51-60 of 426) with videos related to

Sort By:
Pageof 43
European Journal of Medicinal Chemistry|January 23, 2018
Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1KaiJun Jin, Hong Yin, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|October 7, 2008
Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of actionTine Van Neck, Christophe Pannecouque, Els Vanstreels, et al.
European Journal of Medicinal Chemistry|September 21, 2014
Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridizationZhaoqiang Liu, Wenmin Chen, Peng Zhan, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2014
Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19Rosalba Perrone, Elena Butovskaya, Dirk Daelemans, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2004
How a modification (8-aza-3-deaza-2'-deoxyguanosine) influences the quadruplex structure of Hotoda's 6-mer TGGGAG with 5'- and 3'-end modificationsSuzana Jaksa, Bogdan Kralj, Christophe Pannecouque, et al.
European Journal of Medicinal Chemistry|February 5, 2008
Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agentsRavindra K Rawal, Rajkamal Tripathi, S B Katti, et al.
European Journal of Medicinal Chemistry|August 12, 2008
Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitorsYue-Ping Wang, Fen-Er Chen, Erik De Clercq, et al.
Chemistry & Biodiversity|April 9, 2009
Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strainYuan-Zhen Xiong, Fen-Er Chen, Jan Balzarini, et al.
European Journal of Medicinal Chemistry|September 18, 2007
Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activityYuan-Zhen Xiong, Fen-Er Chen, Jan Balzarini, et al.
European Journal of Medicinal Chemistry|July 25, 2009
Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsPeng Zhan, Xinyong Liu, Zengjun Fang, et al.
Pageof 43